Afzalun Nessa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Afzalun Nessa has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
Shahina Tabassum
Chairman, Deptt. of Virology, BSMMU, Shahbag, Dhaka
4 shared publications- Shahjada Selim
Department of Endocrinology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
2 shared publications - Afsana Anwar Miti1 shared publication
- Ayesha Alam Mita
Medical Officer, Department of Virology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
1 shared publication - Farzana Laila1 shared publication
- Habib Shahriar
Department of Virology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Shahbag, Dhaka, Bangladesh
1 shared publication
Latest Publications
- Open Access
- 6 September 2026
- Published by Bangladesh Academy of Sciences in Journal of Medicine
- Vol. 27 (2) , 72-77
Pleural Fluid Interleukin-32 as a Diagnostic Biomarker for Tuberculous Pleural Effusions in Bangladesh: A Cross-Sectional Study
Background: Tuberculous pleural effusion (TPE) is one of the most common types of extrapulmonary tuberculosis, and a definite diagnosis based on biomarkers is very challenging. Interleukin 32 (IL-32) is an inflammatory cytokine, crucial for the host immune response to tuberculosis. The purpose of this study is to determine the performance of IL-32 in the diagnosis of TPE. Materials and methods: This cross-sectional observational study was conducted in the Department of Respiratory Medicine of Bangladesh Medical University (BMU) among 50 participants aged 18-70 years who fit the inclusion and exclusion criteria. Pleural fluid was assessed for IL-32 and ADA via enzyme-linked immunosorbent assay to determine the diagnostic performance and compare them. Results: A total of 23 TPE and 27 non-TPE were identified by means of pleural biopsy findings, and in both instances males were predominant. Mean (±SD) age of TPE participants was 34.6 ± 17.3 years, and that of non-TPE was 57.32 ± 11.42 years. The most common symptoms were weight loss, anorexia, and fever in the TBE group. Mean pleural protein, lymphocyte, and ADA concentrations were significantly different between TPE and non-TPE (p-values <0.05, <0.001, and <0.001, respectively) but not for glucose and LDH (p-values 0.05 and 0.05). Also mean (±SD) pleural IL-32 levels were also significantly elevated in TPE (435.4 +360.3ng/L) compared to non-TPE (130.2 +80.0ng/L), (p value 240.8 pg/ml effectively diagnosed TPE with a sensitivity of 87.3, specificity of 94.3 and area under the curve (AUC) of 0.923. Conclusion: Interleukin-32 may play an important role in the diagnosis of TPE with its high diagnostic accuracy compared with adenosine deaminase. J MEDICINE 2026; 27(2): 72-77
- 6 September 2026
- Published by Bangladesh Academy of Sciences in Journal of Medicine
- Vol. 27 (2) , 72-77
Open AccessPleural Fluid Interleukin-32 as a Diagnostic Biomarker for Tuberculous Pleural Effusions in Bangladesh: A Cross-Sectional Study
Background: Tuberculous pleural effusion (TPE) is one of the most common types of extrapulmonary tuberculosis, and a definite diagnosis based on biomarkers is very challenging. Interleukin 32 (IL-32) is an inflammatory cytokine, crucial for the host immune response to tuberculosis. The purpose of this study is to determine the performance of IL-32 in the diagnosis of TPE. Materials and methods: This cross-sectional observational study was conducted in the Department of Respiratory Medicine of Bangladesh Medical University (BMU) among 50 participants aged 18-70 years who fit the inclusion and exclusion criteria. Pleural fluid was assessed for IL-32 and ADA via enzyme-linked immunosorbent assay to determine the diagnostic performance and compare them. Results: A total of 23 TPE and 27 non-TPE were identified by means of pleural biopsy findings, and in both instances males were predominant. Mean (±SD) age of TPE participants was 34.6 ± 17.3 years, and that of non-TPE was 57.32 ± 11.42 years. The most common symptoms were weight loss, anorexia, and fever in the TBE group. Mean pleural protein, lymphocyte, and ADA concentrations were significantly different between TPE and non-TPE (p-values <0.05, <0.001, and <0.001, respectively) but not for glucose and LDH (p-values 0.05 and 0.05). Also mean (±SD) pleural IL-32 levels were also significantly elevated in TPE (435.4 +360.3ng/L) compared to non-TPE (130.2 +80.0ng/L), (p value 240.8 pg/ml effectively diagnosed TPE with a sensitivity of 87.3, specificity of 94.3 and area under the curve (AUC) of 0.923. Conclusion: Interleukin-32 may play an important role in the diagnosis of TPE with its high diagnostic accuracy compared with adenosine deaminase. J MEDICINE 2026; 27(2): 72-77
- Open Access
- 1 January 2026
- Published by Wiley in International Journal of Hepatology
- Vol. 2026 (1)
Liquid Biopsy–Based Profiling of TP53 Gene Hotspot Mutations in HBV‐Induced Chronic Liver Disease and Hepatocellular Carcinoma Patients: A Study From Bangladesh
Background: The tumor protein ( TP53 ) gene is a common driver gene for somatic mutations in hepatocellular carcinoma(HCC), and detection may provide insight into evaluating disease progression. Circulating cell‐free DNA (cfDNA) from liquid biopsy has emerged as a promising noninvasive biopsy material for identifying potential genetic alterations. This study explored the mutational signature of the TP53 gene in Hepatitis B virus (HBV)–infected chronic liver disease (CLD) and HCC patients from cfDNA. Method: A total of 80 participants: 30 HCC, 30 CLD, and 20 healthy controls were included in this cross‐sectional study. cfDNA was extracted from aseptically collected peripheral venous blood. TP53 (R249S) gene was amplified using selected primers via conventional PCR and visualized on a 2% agarose gel electrophoresis. Amplified products underwent Sanger sequencing; mutational analysis was done using MEGA11 software compared with the reference sequence. Result: TP53 hotspot mutations were found in 23.3% (7/30) of HCC patients. Mutational frequencies were detected: 13.3% (4/30) at position 746G > A (R249S), 6.7% (2/30) at 747G > A (R249S), and 3.3% (1/30) at 735C > T (G245S). Among CLD patients, a single hotspot mutation (3.3%) was detected at position 744G > A/T(R248Q/W). However, no hotspot mutation was detected in healthy controls. All HCC patients with mutations (7/7, 100%) had elevated ALT, AST, serum bilirubin, and AFP levels, and in the unmutated (wild) group, these were 69.6%, 47.8%, 30.4%, and 60.9%, respectively. The mean AST and AFP levels were significantly higher in mutated patients compared with the wild group. Conclusion: Detection of TP53 gene mutations along with biochemical markers in the management of HCC is evident, and it may play an important role in targeted therapy and personalized treatment plans.
- 1 January 2026
- Published by Wiley in International Journal of Hepatology
- Vol. 2026 (1)
Open AccessLiquid Biopsy–Based Profiling of TP53 Gene Hotspot Mutations in HBV‐Induced Chronic Liver Disease and Hepatocellular Carcinoma Patients: A Study From Bangladesh
Background: The tumor protein ( TP53 ) gene is a common driver gene for somatic mutations in hepatocellular carcinoma(HCC), and detection may provide insight into evaluating disease progression. Circulating cell‐free DNA (cfDNA) from liquid biopsy has emerged as a promising noninvasive biopsy material for identifying potential genetic alterations. This study explored the mutational signature of the TP53 gene in Hepatitis B virus (HBV)–infected chronic liver disease (CLD) and HCC patients from cfDNA. Method: A total of 80 participants: 30 HCC, 30 CLD, and 20 healthy controls were included in this cross‐sectional study. cfDNA was extracted from aseptically collected peripheral venous blood. TP53 (R249S) gene was amplified using selected primers via conventional PCR and visualized on a 2% agarose gel electrophoresis. Amplified products underwent Sanger sequencing; mutational analysis was done using MEGA11 software compared with the reference sequence. Result: TP53 hotspot mutations were found in 23.3% (7/30) of HCC patients. Mutational frequencies were detected: 13.3% (4/30) at position 746G > A (R249S), 6.7% (2/30) at 747G > A (R249S), and 3.3% (1/30) at 735C > T (G245S). Among CLD patients, a single hotspot mutation (3.3%) was detected at position 744G > A/T(R248Q/W). However, no hotspot mutation was detected in healthy controls. All HCC patients with mutations (7/7, 100%) had elevated ALT, AST, serum bilirubin, and AFP levels, and in the unmutated (wild) group, these were 69.6%, 47.8%, 30.4%, and 60.9%, respectively. The mean AST and AFP levels were significantly higher in mutated patients compared with the wild group. Conclusion: Detection of TP53 gene mutations along with biochemical markers in the management of HCC is evident, and it may play an important role in targeted therapy and personalized treatment plans.
- Open Access
- 1 October 2025
- Published by Taylor & Francis in International Journal of General Medicine
- Vol. ume 18, 6043-6054
Rubella Seropositivity and Associated Factors Among Young Female Adults in Bangladesh: A Cross-Sectional Study
Purpose: A cross-sectional study was conducted among young female adults aged 18 to 24 years in Bangladesh to assess rubella IgG seropositivity and associated factors. Methods: Data were collected on participants’ sociodemographic and family characteristics, residency and age during 2014 Measles-Rubella campaign, and rubella vaccination history. Blood samples were collected and tested for rubella virus-specific immunoglobulin G (IgG) antibodies (rubella IgG) using chemiluminescence immunoassay. Results: Of the 250 young female adults aged 18– 24 years, 87.20% (95% CI: 83.06%– 91.34%) were seropositive for rubella IgG: 89.47% among the vaccinated, 85.93% among the non-vaccinated, and 88.54% among those with unknown vaccination history. Seropositivity was not significantly associated with reported rubella vaccination history. Titer levels were significantly higher in seropositive participants without a vaccination history (Median 66.75 IU/mL; interquartile range (IQR): 42.53– 98.47) than those with a history (Median 37.30 IU/mL; IQR: 29.70– 65.60). Compared with those from rural locations, participants from urban locations had significantly lower odds of seropositivity (Odds Ratio 0.33; 95% CI: 0.12– 0.92; p = 0.035). Conclusion: A relatively high prevalence of rubella IgG seropositivity was detected. However, approximately one in ten participants remained susceptible to rubella infection during pregnancy and at risk of related adverse outcomes, including congenital rubella syndrome. Seropositivity was not associated with rubella vaccination history suggesting endemic transmission of the rubella virus. The low proportion of participants with a known vaccination history indicates gaps in vaccination documentation. Therefore, well-recorded vaccination histories and strengthened surveillance systems should be developed.
- 1 October 2025
- Published by Taylor & Francis in International Journal of General Medicine
- Vol. ume 18, 6043-6054
Open AccessRubella Seropositivity and Associated Factors Among Young Female Adults in Bangladesh: A Cross-Sectional Study
Purpose: A cross-sectional study was conducted among young female adults aged 18 to 24 years in Bangladesh to assess rubella IgG seropositivity and associated factors. Methods: Data were collected on participants’ sociodemographic and family characteristics, residency and age during 2014 Measles-Rubella campaign, and rubella vaccination history. Blood samples were collected and tested for rubella virus-specific immunoglobulin G (IgG) antibodies (rubella IgG) using chemiluminescence immunoassay. Results: Of the 250 young female adults aged 18– 24 years, 87.20% (95% CI: 83.06%– 91.34%) were seropositive for rubella IgG: 89.47% among the vaccinated, 85.93% among the non-vaccinated, and 88.54% among those with unknown vaccination history. Seropositivity was not significantly associated with reported rubella vaccination history. Titer levels were significantly higher in seropositive participants without a vaccination history (Median 66.75 IU/mL; interquartile range (IQR): 42.53– 98.47) than those with a history (Median 37.30 IU/mL; IQR: 29.70– 65.60). Compared with those from rural locations, participants from urban locations had significantly lower odds of seropositivity (Odds Ratio 0.33; 95% CI: 0.12– 0.92; p = 0.035). Conclusion: A relatively high prevalence of rubella IgG seropositivity was detected. However, approximately one in ten participants remained susceptible to rubella infection during pregnancy and at risk of related adverse outcomes, including congenital rubella syndrome. Seropositivity was not associated with rubella vaccination history suggesting endemic transmission of the rubella virus. The low proportion of participants with a known vaccination history indicates gaps in vaccination documentation. Therefore, well-recorded vaccination histories and strengthened surveillance systems should be developed.
- Open Access
- 10 July 2025
- Published by Bangladesh Academy of Sciences in Bangabandhu Sheikh Mujib Medical University Journal
- Vol. 18 (3) , e83258
Association of climate variability with hepatitis A and E infections in Dhaka (2016–2023)
Background: Acute viral hepatitis, predominantly caused by hepatitis A virus (HAV) and hepatitis E virus (HEV), remains a major global public health issue, especially in low- and middle-income countries. This study was conducted to determine the prevalence of acute hepatitis A and E infections in Dhaka city and to examine the influence of weather conditions on their transmission. Methods: This retrospective study, based on laboratory data, was conducted at the Department of Virology, Bangladesh Medical University from 2016 to 2023. It analysed the test results for anti-HAV-IgM and anti-HEV-IgM antibodies from blood specimens of suspected acute hepatitis cases. The patients’ details and laboratory results were retrieved using the Laboratory Information System, and climatic variables (temperature, humidity, and rainfall) were obtained from the Bangladesh Meteorological Department. Results: In this study, test reports from 19,542 individuals for HAV and 23,249 individuals for HEV were analysed. HAV was detected in 29.5% of the population, and HEV was found in 20.6%. Males were predominantly seropositive for both HAV (65.1%) and HEV (76%). HAV was most common in those aged ≤10 and 11–20 years (37.9%), whereas HEV was most common in the 21–30 years group (40.6%). Higher HAV transmission was observed during autumn and late autumn, while HEV was more prevalent in summer and the rainy season. Conclusion: Acute HAV and HEV infections are common in Dhaka city, and climatic factors affect their spread. Understanding these patterns can improve public health readiness and raise awareness of social health hygiene.
- 10 July 2025
- Published by Bangladesh Academy of Sciences in Bangabandhu Sheikh Mujib Medical University Journal
- Vol. 18 (3) , e83258
Open AccessAssociation of climate variability with hepatitis A and E infections in Dhaka (2016–2023)
Background: Acute viral hepatitis, predominantly caused by hepatitis A virus (HAV) and hepatitis E virus (HEV), remains a major global public health issue, especially in low- and middle-income countries. This study was conducted to determine the prevalence of acute hepatitis A and E infections in Dhaka city and to examine the influence of weather conditions on their transmission. Methods: This retrospective study, based on laboratory data, was conducted at the Department of Virology, Bangladesh Medical University from 2016 to 2023. It analysed the test results for anti-HAV-IgM and anti-HEV-IgM antibodies from blood specimens of suspected acute hepatitis cases. The patients’ details and laboratory results were retrieved using the Laboratory Information System, and climatic variables (temperature, humidity, and rainfall) were obtained from the Bangladesh Meteorological Department. Results: In this study, test reports from 19,542 individuals for HAV and 23,249 individuals for HEV were analysed. HAV was detected in 29.5% of the population, and HEV was found in 20.6%. Males were predominantly seropositive for both HAV (65.1%) and HEV (76%). HAV was most common in those aged ≤10 and 11–20 years (37.9%), whereas HEV was most common in the 21–30 years group (40.6%). Higher HAV transmission was observed during autumn and late autumn, while HEV was more prevalent in summer and the rainy season. Conclusion: Acute HAV and HEV infections are common in Dhaka city, and climatic factors affect their spread. Understanding these patterns can improve public health readiness and raise awareness of social health hygiene.
- Open Access
- 1 January 2024
- Published by Wiley in International Journal of Hepatology
- Vol. 2024 (1) , 4221368
miRNA‐221: A Potential Biomarker of Progressive Liver Injury in Chronic Liver Disease (CLD) due to Hepatitis B Virus (HBV) and Nonalcoholic Fatty Liver Disease (NAFLD)
Background: Early detection of progressive liver damage in chronic liver disease (CLD) patients is crucial for better treatment response. Several studies have shown the association of microRNA (miRNA) in the progression of CLD in regulating cell proliferation, fibrosis, and apoptosis as well as in carcinogenesis.Objectives: The study was aimed at determining the expression of miRNA‐221 among different stages of fibrosis in CLD patients due to hepatitis B virus (HBV) and nonalcoholic fatty liver disease (NAFLD) and thus evaluate its role as an early biomarker in CLD.Methods: A total of 100 participants (75 CLD patients and 25 healthy control) were recruited in this cross‐sectional study and divided into four groups, of which 25 as healthy control, 25 in CLD without fibrosis, 25 were CLD with fibrosis, and 25 were CLD with cirrhosis. Total RNA was extracted from plasma followed by cDNA synthesis, and finally, the expression of miRNA‐221 was analyzed for its diagnostic potential as a single biomarker using the qRT‐PCR method.Results: The plasma level of miRNA‐221 was significantly upregulated in different fibrosis stages of CLD (p < 0.05), and this upregulation was positively correlated with the progression of fibrosis (p < 0.05). Significantly increased expression of miRNA‐221 was found in NAFLD patients compared to HBV patients in the CLD without fibrosis patient group (p < 0.05), while expression of miRNA‐221 was significantly upregulated among HBV patients in the CLD with the fibrosis group. miRNA‐221 showed high diagnostic accuracy in discriminating different stages of fibrosis from healthy control (p < 0.05).Conclusion: miRNA‐221 may be used as a potential plasma biomarker for early prediction of fibrosis progression in CLD patients.
- 1 January 2024
- Published by Wiley in International Journal of Hepatology
- Vol. 2024 (1) , 4221368
Open AccessmiRNA‐221: A Potential Biomarker of Progressive Liver Injury in Chronic Liver Disease (CLD) due to Hepatitis B Virus (HBV) and Nonalcoholic Fatty Liver Disease (NAFLD)
Background: Early detection of progressive liver damage in chronic liver disease (CLD) patients is crucial for better treatment response. Several studies have shown the association of microRNA (miRNA) in the progression of CLD in regulating cell proliferation, fibrosis, and apoptosis as well as in carcinogenesis.Objectives: The study was aimed at determining the expression of miRNA‐221 among different stages of fibrosis in CLD patients due to hepatitis B virus (HBV) and nonalcoholic fatty liver disease (NAFLD) and thus evaluate its role as an early biomarker in CLD.Methods: A total of 100 participants (75 CLD patients and 25 healthy control) were recruited in this cross‐sectional study and divided into four groups, of which 25 as healthy control, 25 in CLD without fibrosis, 25 were CLD with fibrosis, and 25 were CLD with cirrhosis. Total RNA was extracted from plasma followed by cDNA synthesis, and finally, the expression of miRNA‐221 was analyzed for its diagnostic potential as a single biomarker using the qRT‐PCR method.Results: The plasma level of miRNA‐221 was significantly upregulated in different fibrosis stages of CLD (p < 0.05), and this upregulation was positively correlated with the progression of fibrosis (p < 0.05). Significantly increased expression of miRNA‐221 was found in NAFLD patients compared to HBV patients in the CLD without fibrosis patient group (p < 0.05), while expression of miRNA‐221 was significantly upregulated among HBV patients in the CLD with the fibrosis group. miRNA‐221 showed high diagnostic accuracy in discriminating different stages of fibrosis from healthy control (p < 0.05).Conclusion: miRNA‐221 may be used as a potential plasma biomarker for early prediction of fibrosis progression in CLD patients.
- Open Access
- 25 August 2023
- Published by Wiley
Robust cellular immune responses to BNT162b2 SARS-CoV-2 mRNA vaccine in T2DM individuals in Bangladesh
Introduction: Diabetes being one of the most common comorbidities of COVID-19, is prioritized for SARS-CoV-2 vaccination. To evaluate the T-cell mediated immune responses in T2DM, this study assessed and compared IFN-\(\gamma\) and IL-2 secreting PBMCs against the SARS-CoV-2 BNT162b2 mRNA vaccine. Methods: 19 known cases of type 2 diabetes and 16 healthy controls were included through purposive sampling and were regularly sampled before 1 st dose, after 1 st and 2 nd dose of vaccination. Ex-vivo ELISpot assays for IFN-\(\gamma\) and IL-2 were done using isolated PBMCs along with HbA1c status and SARS-CoV-2 spike-specific IgG antibody. A p -value < 0.05 was considered significant. Results: All participants were seroconverted after 1 st dose and showed a robust rise of IFN-\(\gamma\) and IL-2 secreting PBMCs counts in T2DM participants irrespective of hypertension, gender and age after 2 doses of vaccination. However, IFN-\(\gamma\) secreting PBMCs counts were significantly lower in type 2 diabetic group than healthy control group after 1 st dose. Conclusion: Although type 2 diabetic participants had a lower response initially, BNT162b2 mRNA vaccine overall induces a robust T-cell mediated immune response- 25 August 2023
- Published by Wiley
Open AccessRobust cellular immune responses to BNT162b2 SARS-CoV-2 mRNA vaccine in T2DM individuals in Bangladesh
Introduction: Diabetes being one of the most common comorbidities of COVID-19, is prioritized for SARS-CoV-2 vaccination. To evaluate the T-cell mediated immune responses in T2DM, this study assessed and compared IFN-\(\gamma\) and IL-2 secreting PBMCs against the SARS-CoV-2 BNT162b2 mRNA vaccine. Methods: 19 known cases of type 2 diabetes and 16 healthy controls were included through purposive sampling and were regularly sampled before 1 st dose, after 1 st and 2 nd dose of vaccination. Ex-vivo ELISpot assays for IFN-\(\gamma\) and IL-2 were done using isolated PBMCs along with HbA1c status and SARS-CoV-2 spike-specific IgG antibody. A p -value < 0.05 was considered significant. Results: All participants were seroconverted after 1 st dose and showed a robust rise of IFN-\(\gamma\) and IL-2 secreting PBMCs counts in T2DM participants irrespective of hypertension, gender and age after 2 doses of vaccination. However, IFN-\(\gamma\) secreting PBMCs counts were significantly lower in type 2 diabetic group than healthy control group after 1 st dose. Conclusion: Although type 2 diabetic participants had a lower response initially, BNT162b2 mRNA vaccine overall induces a robust T-cell mediated immune response - Open Access
- 6 June 2018
- Published by Bangladesh Academy of Sciences in Bangladesh Medical Research Council Bulletin
- Vol. 44 (1) , 1-8
Human Leukocyte Antigen: Class I Allele Frequencies and Haplotype Distributionin a Tertiary Care Hospital in Bangladesh
Human leukocyte antigen (HLA) are cell surface glycoproteins encoded by Major Histocompatibility Complex (MHC) geneof human genome. HLA antigen frequency and haplotype distribution are useful for determining disease associations, origin, migration and genetic relationships between populations and predicting the outcome of transplantation. Thus, the present study was carried outto identify HLA class I (HLA-A and HLA-B) antigen and haplotype distribution among a selected Bangladeshi population. This retrospective study was conducted among 1070 individuals who were referred by cliniciansfor HLA typing at the Tissue Typing Laboratory of the Department of Virology, Bangabandhu Sheikh Mujib Medical University (BSMMU) during the period 2009 to 2011. For HLA typing, Blood was collected in heparin containing tube and the laboratory tests were performed by the microlymphocytotoxicity technique according to manufacturer’s instructions.Out of 19 HLA-A and 37HLA-B antigens tested, a total of 19/19 and 36/37 antigens were detectedrespectively in this study. The most frequent antigens of HLA-A and HLA-B detected were A11 (25.4%), A24 (16.6%), B75 (18.1%) and B35 (11.3%). The least antigen frequency detected for HLA-A locus were A69 (0.09%), A26 (0.28%), A34 (0.28%), while for HLA-B locus were B81 (0.09%) and B56 (0.09%). Among the HLA-A and HLA-B antigens, some alleles were found to be homozygote such as A11 (4.0%), A2 (2.7%), A24 (2.1%) andB75 (2.4%), B35 (1.8%), and B44 (1.4%) respectively. The most frequent haplotype in the study populationwereA11: B75 (4.9%). The most frequent antigens of HLA-A and HLA-B detected were A11 (25.4%), B75 (18.1%) respectively. The distribution of HLA haplotypes among the study population indicates that it has the influence of Oriental and Asian populations. Thus, this study will be helpful to provide valuable information for population genetics and HLA disease association analysis.Bangladesh Med Res Counc Bull 2018; 44(1):01-08
- 6 June 2018
- Published by Bangladesh Academy of Sciences in Bangladesh Medical Research Council Bulletin
- Vol. 44 (1) , 1-8
Open AccessHuman Leukocyte Antigen: Class I Allele Frequencies and Haplotype Distributionin a Tertiary Care Hospital in Bangladesh
Human leukocyte antigen (HLA) are cell surface glycoproteins encoded by Major Histocompatibility Complex (MHC) geneof human genome. HLA antigen frequency and haplotype distribution are useful for determining disease associations, origin, migration and genetic relationships between populations and predicting the outcome of transplantation. Thus, the present study was carried outto identify HLA class I (HLA-A and HLA-B) antigen and haplotype distribution among a selected Bangladeshi population. This retrospective study was conducted among 1070 individuals who were referred by cliniciansfor HLA typing at the Tissue Typing Laboratory of the Department of Virology, Bangabandhu Sheikh Mujib Medical University (BSMMU) during the period 2009 to 2011. For HLA typing, Blood was collected in heparin containing tube and the laboratory tests were performed by the microlymphocytotoxicity technique according to manufacturer’s instructions.Out of 19 HLA-A and 37HLA-B antigens tested, a total of 19/19 and 36/37 antigens were detectedrespectively in this study. The most frequent antigens of HLA-A and HLA-B detected were A11 (25.4%), A24 (16.6%), B75 (18.1%) and B35 (11.3%). The least antigen frequency detected for HLA-A locus were A69 (0.09%), A26 (0.28%), A34 (0.28%), while for HLA-B locus were B81 (0.09%) and B56 (0.09%). Among the HLA-A and HLA-B antigens, some alleles were found to be homozygote such as A11 (4.0%), A2 (2.7%), A24 (2.1%) andB75 (2.4%), B35 (1.8%), and B44 (1.4%) respectively. The most frequent haplotype in the study populationwereA11: B75 (4.9%). The most frequent antigens of HLA-A and HLA-B detected were A11 (25.4%), B75 (18.1%) respectively. The distribution of HLA haplotypes among the study population indicates that it has the influence of Oriental and Asian populations. Thus, this study will be helpful to provide valuable information for population genetics and HLA disease association analysis.Bangladesh Med Res Counc Bull 2018; 44(1):01-08
- Open Access
- 15 April 2018
- Published by Bangladesh Academy of Sciences in Bangladesh Medical Research Council Bulletin
- Vol. 43 (3) , 101-107
BK Virus Infection:A Hidden Threat for Renal Transplant Recipients
BK virus (BKV) infection has become an important concern for renal transplant recipients, as it may cause nephropathy in transplant patients receiving immunosuppressive therapy resulting in renal dysfunction and possibly, graft loss. This crosssectional study was carried out at the Department of Virology, Bangabandhu Sheikh Mujib Medical University (BSMMU) from March 2015 to June 2016, aimedto detect the incidence of BKV infection among transplant recipients from Bangladesh. A total of 30randomly selected adult renal transplant recipients and 15 healthy controls were included in this study.Their blood and urine samples were collected at 4 and 12 weeks of post transplantation, and tested for BKV DNA by quantitative real-time polymerase chain reaction. The serum creatinine levels were measured along with other routine investigations at the Department Biochemistry, BSMMU.Virological analysis showed, 8 (26.6%) patients had detectable BKV DNA at 4 weeks (1 month). Of them, 23.3% (7/30) had viruria and 3.3% (1/30) had viraemia. No BKV DNA was detected either in blood or in urine samples of healthy controls. Incidence of BKV infection found significantly higher (p<0.02) in transplant patients than healthy controls. However, their serum creatinine value was not significantly higher than that of the BKV DNA negative patients. At third month (12 weeks post transplantation), BKVviruria and/or viraemia were detected among 23.3% (7/30) patients where 13.3% (4/30) patients were newly detected who were previously ( at 4 weeks of transplant) negative; only 1 (3.3%) patient had both viraemia and viruria. There was significant variation (p<0.05) in mean serum creatinine value of BKV DNA positive and BKV DNA negative recipients at third month follow-up.Significantly higher incidence of BKV infection among transplant patients indicates thatit is very likely occurring in transplantation recipients, andBKV screening test should be included in routine postoperative follow-up investigations for early detection; and thus prevent the graft loss due to BKV nephropathy.
- 15 April 2018
- Published by Bangladesh Academy of Sciences in Bangladesh Medical Research Council Bulletin
- Vol. 43 (3) , 101-107
Open AccessBK Virus Infection:A Hidden Threat for Renal Transplant Recipients
BK virus (BKV) infection has become an important concern for renal transplant recipients, as it may cause nephropathy in transplant patients receiving immunosuppressive therapy resulting in renal dysfunction and possibly, graft loss. This crosssectional study was carried out at the Department of Virology, Bangabandhu Sheikh Mujib Medical University (BSMMU) from March 2015 to June 2016, aimedto detect the incidence of BKV infection among transplant recipients from Bangladesh. A total of 30randomly selected adult renal transplant recipients and 15 healthy controls were included in this study.Their blood and urine samples were collected at 4 and 12 weeks of post transplantation, and tested for BKV DNA by quantitative real-time polymerase chain reaction. The serum creatinine levels were measured along with other routine investigations at the Department Biochemistry, BSMMU.Virological analysis showed, 8 (26.6%) patients had detectable BKV DNA at 4 weeks (1 month). Of them, 23.3% (7/30) had viruria and 3.3% (1/30) had viraemia. No BKV DNA was detected either in blood or in urine samples of healthy controls. Incidence of BKV infection found significantly higher (p<0.02) in transplant patients than healthy controls. However, their serum creatinine value was not significantly higher than that of the BKV DNA negative patients. At third month (12 weeks post transplantation), BKVviruria and/or viraemia were detected among 23.3% (7/30) patients where 13.3% (4/30) patients were newly detected who were previously ( at 4 weeks of transplant) negative; only 1 (3.3%) patient had both viraemia and viruria. There was significant variation (p<0.05) in mean serum creatinine value of BKV DNA positive and BKV DNA negative recipients at third month follow-up.Significantly higher incidence of BKV infection among transplant patients indicates thatit is very likely occurring in transplantation recipients, andBKV screening test should be included in routine postoperative follow-up investigations for early detection; and thus prevent the graft loss due to BKV nephropathy.
- Open Access
- 29 March 2017
- Published by Bangladesh Academy of Sciences in Bangladesh Medical Research Council Bulletin
- Vol. 42 (2) , 84-89
Rubella Antibody Prevalence and Immunogenicity of Single Dose Rubella Vaccine Among 16 – 25 Years Girls from Bangladesh
Rubella virus infection during pregnancy is an important cause of blindness, deafness, congenital heart disease, and mental retardation of the foetus. Multiple sero-surveys of rubella antibody among reproductive aged females of Bangladesh showed that 20-30% of them remain susceptible to rubella as rubella vaccination is yet not included in our national immunization program for adolescent and adult girls. The present study was designed to conduct a sero-survey among unmarried girls of 16 to 25 years to assess their serological status in terms of natural rubella infection and vaccinate the rubella susceptible individuals with a single dose of rubella vaccine to evaluate the immunogenicity of the vaccine. A total of 344 randomly selected unmarried, apparently healthy college students were enrolled and investigated for rubella IgG and IgM antibodies at the Department of Virology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka. Girls who were found to be negative for both rubella IgG and IgM were vaccinated with a single dose of rubella vaccine and tested for rubella antibody after four to six weeks of vaccination. Quantitative analysis of rubella IgG showed that a total of 68.87% study population had protective rubella antibody, 29.36% were susceptible to rubella and 1.74% experienced recent rubella infection. After vaccination, rubella antibody positivity was found to be 100% among 99 (98.02%) of 101 vaccinated girls who were tested for anti rubella IgG. There was statistically significant increase (p <0.001, Paired t Test) in anti-Rubella IgG titres among pre-vaccination and post-vaccination sera. The findings of the study showed that it is mandatory to include young girls in the national immunization programme and immunize them with a single dose of rubella vaccine which was found to be 100% effective.
- 29 March 2017
- Published by Bangladesh Academy of Sciences in Bangladesh Medical Research Council Bulletin
- Vol. 42 (2) , 84-89
Open AccessRubella Antibody Prevalence and Immunogenicity of Single Dose Rubella Vaccine Among 16 – 25 Years Girls from Bangladesh
Rubella virus infection during pregnancy is an important cause of blindness, deafness, congenital heart disease, and mental retardation of the foetus. Multiple sero-surveys of rubella antibody among reproductive aged females of Bangladesh showed that 20-30% of them remain susceptible to rubella as rubella vaccination is yet not included in our national immunization program for adolescent and adult girls. The present study was designed to conduct a sero-survey among unmarried girls of 16 to 25 years to assess their serological status in terms of natural rubella infection and vaccinate the rubella susceptible individuals with a single dose of rubella vaccine to evaluate the immunogenicity of the vaccine. A total of 344 randomly selected unmarried, apparently healthy college students were enrolled and investigated for rubella IgG and IgM antibodies at the Department of Virology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka. Girls who were found to be negative for both rubella IgG and IgM were vaccinated with a single dose of rubella vaccine and tested for rubella antibody after four to six weeks of vaccination. Quantitative analysis of rubella IgG showed that a total of 68.87% study population had protective rubella antibody, 29.36% were susceptible to rubella and 1.74% experienced recent rubella infection. After vaccination, rubella antibody positivity was found to be 100% among 99 (98.02%) of 101 vaccinated girls who were tested for anti rubella IgG. There was statistically significant increase (p <0.001, Paired t Test) in anti-Rubella IgG titres among pre-vaccination and post-vaccination sera. The findings of the study showed that it is mandatory to include young girls in the national immunization programme and immunize them with a single dose of rubella vaccine which was found to be 100% effective.
- Open Access
- 28 July 2016
- Published by Bangladesh Academy of Sciences in Bangladesh Journal of Medical Microbiology
- Vol. 10 (2) , 9-13
Correlation of IP-10 gene expression with Serum alanine transaminase (ALT) levels and Hepatitis B viral load in cirrhosis and hepatocellular carcinoma (HCC) patients.
Interferon-gamma induced protein 10 (IP-10), a chemokine is suggested to be involved in liver injury during Hepatitis B virus infection (HBV). The increase of IP-10 is a critical step for recruitment of inflammatory cells to the local focus of the liver and hepatopathology. This study was designed to assess the correlation of IP-10 gene expression with HBV-DNA and serumAlanine transaminase(ALT) in patients with cirrhosis and HCC.The study was conducted among 60 patients. The study populationwere divided into four groups (15 in each groups)-HBV positive cirrhosis, HBV negative cirrhosis, HBV positiveHCC and HBV negative HCC. Expression of IP-10 gene was observed using real time PCR.IP-10 gene expressions in the above mentioned groups were correlated with serum ALT level and HBV viral load.IP-10 gene was significantly higher in HBV-positive patients with HCC than HBVpositive cirrhosis. Similarly, the expression of IP-10 was significantly higher in HBV-positive HCC than HBVnegative HCC patients. However, the expression of IP-10 was reduced in HBV-positive cirrhosis in comparison with HBV-negative cirrhosis.IP-10 gene expression in liver was not correlated with the serum levels of ALT in any of the study groups. HBV- DNA load also did not correlated with IP-10 gene expression in HBV positive HCC and HBV positive cirrhosis patients.This study shows that there was no significant change with the expression of IP-10 gene in any of the study groups with ALT level or viral load, though differential expression of IP-10 gene were observed in cirrhosis and HCC patients. Bangladesh J Med Microbiol 2016; 10 (2): 9-13
- 28 July 2016
- Published by Bangladesh Academy of Sciences in Bangladesh Journal of Medical Microbiology
- Vol. 10 (2) , 9-13
Open AccessCorrelation of IP-10 gene expression with Serum alanine transaminase (ALT) levels and Hepatitis B viral load in cirrhosis and hepatocellular carcinoma (HCC) patients.
Interferon-gamma induced protein 10 (IP-10), a chemokine is suggested to be involved in liver injury during Hepatitis B virus infection (HBV). The increase of IP-10 is a critical step for recruitment of inflammatory cells to the local focus of the liver and hepatopathology. This study was designed to assess the correlation of IP-10 gene expression with HBV-DNA and serumAlanine transaminase(ALT) in patients with cirrhosis and HCC.The study was conducted among 60 patients. The study populationwere divided into four groups (15 in each groups)-HBV positive cirrhosis, HBV negative cirrhosis, HBV positiveHCC and HBV negative HCC. Expression of IP-10 gene was observed using real time PCR.IP-10 gene expressions in the above mentioned groups were correlated with serum ALT level and HBV viral load.IP-10 gene was significantly higher in HBV-positive patients with HCC than HBVpositive cirrhosis. Similarly, the expression of IP-10 was significantly higher in HBV-positive HCC than HBVnegative HCC patients. However, the expression of IP-10 was reduced in HBV-positive cirrhosis in comparison with HBV-negative cirrhosis.IP-10 gene expression in liver was not correlated with the serum levels of ALT in any of the study groups. HBV- DNA load also did not correlated with IP-10 gene expression in HBV positive HCC and HBV positive cirrhosis patients.This study shows that there was no significant change with the expression of IP-10 gene in any of the study groups with ALT level or viral load, though differential expression of IP-10 gene were observed in cirrhosis and HCC patients. Bangladesh J Med Microbiol 2016; 10 (2): 9-13